What's New View more articles
WinS Network launched to connect women researchers
Officially ​launched on 21 March 2017, the Women-in-Science (WinS) Network, a brainchild of Prof Koh Woon Puay, Office of Clinical Sciences, Duke-NUS Medical School, aims to connect women researchers in the SingHealth Duke-NUS Academic Medical Centre for mentorship, mutual support and networking opportunities.
Call for entries: SingHealth Publish! Award
Application for the SingHealth Publish! Award is now open! The Award aims to give accolade to SingHealth researchers who have published quality articles in internationally acclaimed peer-reviewed scientific or medical journals. Two types of awards are available, SingHealth Public! Award and the Soo Khee Chee Publication Award​. The closing date for submission is 7 April 2017.
Successful second run of SingHealth Duke-NUS Research Skills Workshop
For the second year in a row, the SingHealth Duke-NUS Research Skills Workshop successfully provided participants with an insightful introduction to the joys and challenges of undertaking a career in academic medicine. Find out more about the four-day Workshop jointly run by Prof Keith Sullivan, Duke University Medical Centre and Prof Koh Woon Puay, Office of Clinical Sciences, Duke-NUS Medical School. 
How to mend a broken heart (better)
In a study published in The Journal of Clinical Investigation, Dr Manvendra Singh, Duke-NUS Medical School, and his team discovered how a signalling pathway, Hippo, controls fibrotic tissue or scar formations after a heart attack. This discovery may lead to the development of new drugs to treat heart failure patients by inhibiting the formation of excessive fibrotic tissue in order to preserve heart function.
Home-grown blood cancer drug to start patient trials
The developers of Sing​apore's second publicly funded cancer drug candidate, ETC-206, hope to start trials in August. Meant for those suffering from later-stage cancer, ETC-206 was primarily developed by ​​A*STAR's Experimental Therapeutics Centre and the Drug Discovery and Development Unit, as well as Duke-NUS Medical School. The drug, which is orally administered, will be tested on blood cancer patients in groups of three. Clinical trials began last December and will test up to 34 healthy volunteers.
Voices @ Research: Time for food and glucose levels in pregnant women
​Dr Loy See Ling, Research Fellow, KK Women's and Children Hospital, is investigating preconception and pregnancy prospective cohort studies in Singapore - namely the 'Growing Up in Singapore Towards Healthy Outcomes' (GUSTO) study and 'Singapore PREconception Study of long-Term maternal and child Outcomes' (SPRESTO) study.